H. J. Senn

561 citations
8 papers · 406 indexed · h-index 5
Topics
Cancer Treatment and Pharmacology (4 papers)Acute Myeloid Leukemia Research (2 papers)Chemotherapy-induced cardiotoxicity and mitigation (2 papers)
Partner nations
SwitzerlandUnited States

In The Last Decade

H. J. Senn

7 papers receiving 348 citations

Peers

H. J. Senn
Comparison fields: 5 of 55
  • Oncology 237
  • Pulmonary and Respiratory Medicine 184
  • Molecular Biology 108
  • Surgery 100
  • Epidemiology 98
Replace Charles J. McPeak with:
Charles J. McPeak United States
Stanford Cade United Kingdom
Andreja Zidar Slovenia
Aylin Örgen Çallı Türkiye
K. Khanfir Switzerland
Yoshinari Imajo Japan
Horn Rc
Hal E. Palmer United States
Emad Raddaoui Saudi Arabia
Priya Rao United States
H. J. Senn relative to Charles J. McPeak United States Charles J. McPeak's profile →
Citations per field
00.5×
Charles J. McPeak · 1×
Citations per year

Countries citing papers authored by H. J. Senn

Since Specialization
Citations

This map shows the geographic impact of H. J. Senn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. J. Senn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. J. Senn more than expected).

Fields of papers citing papers by H. J. Senn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. J. Senn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. J. Senn. The network helps show where H. J. Senn may publish in the future.

Co-authorship network of co-authors of H. J. Senn

This figure shows the co-authorship network connecting the top 25 collaborators of H. J. Senn. A scholar is included among the top collaborators of H. J. Senn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. J. Senn. H. J. Senn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 0
2 6
3 5
4
VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules.
147
5
[The treatment of acute myelocytic leukemia during the first recurrence by means of a new cytostatic combination].
1
6
[Therapeutic experiences using the new podophyllotoxin derivative VP 16-213 in malignant human tumors].
6
7 238
8
[Thrombocytosis in malignant tumors].
3

About H. J. Senn

H. J. Senn is a scholar working on Oncology, Hematology and Dermatology, having authored 8 papers that have together received 406 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Acute Myeloid Leukemia Research (2 papers) and Chemotherapy-induced cardiotoxicity and mitigation (2 papers). The work is most often cited by research in Oncology (237 citations), Pulmonary and Respiratory Medicine (184 citations) and Dermatology (37 citations). H. J. Senn has collaborated with scholars based in Switzerland and United States. Frequent co-authors include Engracio P. Cortes, Johannes Blom, James F. Holland, Oliver Glidewell, Jaw J. Wang, Lucius F. Sinks, Arthur Bank, Roland Sonntag, Franco Cavalli and Kurt Brunner. Their work appears in journals such as New England Journal of Medicine, Clinical Orthopaedics and Related Research and Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026